Works about ULCERATIVE colitis
Results: 5000
The causal impact of genetically predicted inflammatory bowel disease on extraintestinal manifestations: a mendelian randomization study.
- Published in:
- BMC Gastroenterology, 2025, v. 25, n. 1, p. 1, doi. 10.1186/s12876-024-03566-4
- By:
- Publication type:
- Article
Epidemiology and care structures for children and adolescents and young adults up to the 26th year of life with inflammatory bowel diseases (IBD) in Leipzig/Saxony/Germany.
- Published in:
- Journal of Public Health: From Theory to Practice (2198-1833), 2018, v. 26, n. 4, p. 437, doi. 10.1007/s10389-017-0884-2
- By:
- Publication type:
- Article
Prediction of vedolizumab efficacy in ulcerative colitis: a nomogram incorporating pathological feature and serological marker.
- Published in:
- Clinical & Experimental Medicine, 2025, v. 25, n. 1, p. 1, doi. 10.1007/s10238-025-01601-6
- By:
- Publication type:
- Article
Role of PD-L1 in mediating the effect of lipid on ulcerative colitis: a mediation Mendelian randomization study.
- Published in:
- Frontiers in Genetics, 2025, p. 1, doi. 10.3389/fgene.2025.1390605
- By:
- Publication type:
- Article
L'arrivée tant attendue des biothérapies ciblant l'IL-23 dans la prise en charge des MICI.
- Published in:
- Hépato-Gastro & Oncologie Digestive, 2025, v. 32, p. 6, doi. 10.1684/hpg.2025.2949
- By:
- Publication type:
- Article
Vers de nouveaux objectifs thérapeutiques dans les MICI.
- Published in:
- Hépato-Gastro & Oncologie Digestive, 2025, v. 32, p. 27, doi. 10.1684/hpg.2025.2948
- By:
- Publication type:
- Article
L'arrivée des anti-IL23 se précise.
- Published in:
- 2025
- By:
- Publication type:
- Editorial
Regards croisés sur la place de l'ustékinumab dans la maladie de Crohn dans les recommandations françaises, européennes et américaines.
- Published in:
- Hépato-Gastro & Oncologie Digestive, 2025, v. 32, p. 32, doi. 10.1684/hpg.2025.2945
- By:
- Publication type:
- Article
Potential predictors of efficacy outcomes following tofacitinib dose reduction in patients with ulcerative colitis in stable remission: a post hoc analysis of outcomes from the RIVETING study.
- Published in:
- Therapeutic Advances in Gastroenterology, 2025, p. 1, doi. 10.1177/17562848251318849
- By:
- Publication type:
- Article
Prediction of vedolizumab efficacy in ulcerative colitis: a nomogram incorporating pathological feature and serological marker.
- Published in:
- Clinical & Experimental Medicine, 2025, v. 25, n. 1, p. 1, doi. 10.1007/s10238-025-01601-6
- By:
- Publication type:
- Article
Patchoulene epoxide mitigates colitis and hepatic damage induced by dextran sulfate sodium by regulating the colonic microbiota and purine metabolism.
- Published in:
- Frontiers in Immunology, 2025, p. 1, doi. 10.3389/fimmu.2025.1509114
- By:
- Publication type:
- Article
Neurological complications in children and adolescent with Inflammatory Bowel diseases.
- Published in:
- Zagazig University Medical Journal, 2025, v. 31, p. 346, doi. 10.21608/zumj.2024.280809.3302
- By:
- Publication type:
- Article
Dual Therapy in Inflammatory Bowel Disease.
- Published in:
- Biomolecules (2218-273X), 2025, v. 15, n. 2, p. 222, doi. 10.3390/biom15020222
- By:
- Publication type:
- Article
pH-Dependent Drug Delivery Systems for Ulcerative Colitis Treatment.
- Published in:
- Pharmaceutics, 2025, v. 17, n. 2, p. 226, doi. 10.3390/pharmaceutics17020226
- By:
- Publication type:
- Article
Drug Development in Inflammatory Bowel Diseases: What Is Next?
- Published in:
- Pharmaceuticals (14248247), 2025, v. 18, n. 2, p. 190, doi. 10.3390/ph18020190
- By:
- Publication type:
- Article
Enhancing Tetrahydrocannabinol's Therapeutic Efficacy in Inflammatory Bowel Disease: The Roles of Cannabidiol and the Cannabinoid 1 Receptor Allosteric Modulator ZCZ011.
- Published in:
- Pharmaceuticals (14248247), 2025, v. 18, n. 2, p. 148, doi. 10.3390/ph18020148
- By:
- Publication type:
- Article
Danggui Beimu Kushen Pill Alleviates Colitis-Induced Inflammation in Mice by Regulating the IL-6/IL-6R and IL-17A/IL-17RA Signaling Pathways.
- Published in:
- Pharmaceuticals (14248247), 2025, v. 18, n. 2, p. 141, doi. 10.3390/ph18020141
- By:
- Publication type:
- Article
Fecal Microbiota Transplantation as a Treatment for Granulomatous Colitis in a French Bulldog: A Case Report.
- Published in:
- Microorganisms, 2025, v. 13, n. 2, p. 366, doi. 10.3390/microorganisms13020366
- By:
- Publication type:
- Article
The Diagnostic Significance of SLC26A2 and Its Potential Role in Ulcerative Colitis.
- Published in:
- Biomedicines, 2025, v. 13, n. 2, p. 461, doi. 10.3390/biomedicines13020461
- By:
- Publication type:
- Article
High-Throughput Whole-Exome Sequencing and Large-Scale Computational Analysis to Identify the Genetic Biomarkers to Predict the Vedolizumab Response Status in Inflammatory Bowel Disease Patients from Saudi Arabia.
- Published in:
- Biomedicines, 2025, v. 13, n. 2, p. 459, doi. 10.3390/biomedicines13020459
- By:
- Publication type:
- Article
Novel Insights into the Pathogenesis of Inflammatory Bowel Diseases.
- Published in:
- Biomedicines, 2025, v. 13, n. 2, p. 305, doi. 10.3390/biomedicines13020305
- By:
- Publication type:
- Article
Anti-Inflammatory Potential of Wampee (Clausena lansium (Lour.) Skeels) Polyphenol Extract in Ulcerative Colitis: Gut Microbiota and TLR4-p38 MAPK/NF-κB Signaling Axis Regulation.
- Published in:
- Foods, 2025, v. 14, n. 4, p. 619, doi. 10.3390/foods14040619
- By:
- Publication type:
- Article
Investigating the Alleviating Effect of Fucoidan from Apostichopus japonicus on Ulcerative Colitis by Mice Experiments and In Vitro Simulation of Human Fecal Fermentation.
- Published in:
- Foods, 2025, v. 14, n. 4, p. 574, doi. 10.3390/foods14040574
- By:
- Publication type:
- Article
Comparative Outcomes of Adalimumab and Infliximab Dose Escalation in Inflammatory Bowel Disease Patients Failing First-Line Biologic Treatment.
- Published in:
- Journal of Clinical Medicine, 2025, v. 14, n. 4, p. 1228, doi. 10.3390/jcm14041228
- By:
- Publication type:
- Article
Quality of life of inflammatory bowel diseases patients in france with EQ-5D-5 L: the QALY-MICI study.
- Published in:
- Quality of Life Research, 2025, v. 34, n. 2, p. 405, doi. 10.1007/s11136-024-03821-x
- By:
- Publication type:
- Article
Disproportionality analysis of upadacitinib-related adverse events in inflammatory bowel disease using the FDA adverse event reporting system.
- Published in:
- Frontiers in Pharmacology, 2025, p. 1, doi. 10.3389/fphar.2025.1436183
- By:
- Publication type:
- Article
A Hepatic Oxidative Metabolite of Palmatine Ameliorates DSS-Induced Ulcerative Colitis by Regulating Macrophage Polarization Through AMPK/NF-κB Pathway.
- Published in:
- American Journal of Chinese Medicine, 2025, v. 53, n. 1, p. 285, doi. 10.1142/S0192415X25500119
- By:
- Publication type:
- Article
Telehealth—An Environmentally Friendly Way to Take Care of Patients with Inflammatory Bowel Disease.
- Published in:
- Medicina (1010660X), 2025, v. 61, n. 2, p. 332, doi. 10.3390/medicina61020332
- By:
- Publication type:
- Article
Impact of Vitamins, Antibiotics, Probiotics, and History of COVID-19 on the Gut Microbiome in Ulcerative Colitis Patients: A Cross-Sectional Study.
- Published in:
- Medicina (1010660X), 2025, v. 61, n. 2, p. 284, doi. 10.3390/medicina61020284
- By:
- Publication type:
- Article
Pharmacogenetics in Response to Biological Agents in Inflammatory Bowel Disease: A Systematic Review.
- Published in:
- International Journal of Molecular Sciences, 2025, v. 26, n. 4, p. 1760, doi. 10.3390/ijms26041760
- By:
- Publication type:
- Article
In Vitro Assessment of Bacillus thuringiensis Exopolysaccharides and Their Effects on Gut Microbiota from Ulcerative Colitis In Vitro.
- Published in:
- International Journal of Molecular Sciences, 2025, v. 26, n. 4, p. 1692, doi. 10.3390/ijms26041692
- By:
- Publication type:
- Article
Health Benefits of Montmorency Tart Cherry Juice Supplementation in Adults with Mild to Moderate Ulcerative Colitis; A Placebo Randomized Controlled Trial.
- Published in:
- Life (2075-1729), 2025, v. 15, n. 2, p. 306, doi. 10.3390/life15020306
- By:
- Publication type:
- Article
Electrochemical, Real-Time Monitoring of Hydrogen Peroxide in Drosophila (Fruit Fly) Intestines Using a Carbon Fiber Microelectrode (CFME) Modified with Platinum Nanoparticles (PtNPs).
- Published in:
- Analytical Letters, 2025, v. 58, n. 7, p. 1214, doi. 10.1080/00032719.2024.2359079
- By:
- Publication type:
- Article
Causal Relationship between Branched-Chain Amino Acids and Inflammatory Bowel Disease: A Bidirectional and Multivariable Mendelian Randomization Study.
- Published in:
- British Journal of Hospital Medicine (17508460), 2025, v. 86, n. 2, p. 1, doi. 10.12968/hmed.2024.0722
- By:
- Publication type:
- Article
Wieloletnia cukrzyca u chorego z wrzodziejącym zapaleniem jelita grubego -- czy to na pewno cukrzyca typu 2?
- Published in:
- Family Medicine Forum / Forum Medycyny Rodzinnej, 2025, v. 19, n. 1, p. 33
- By:
- Publication type:
- Article
Ulcerative colitis and patient self-management.
- Published in:
- Practice Nursing, 2014, v. 25, n. 8, p. 382, doi. 10.12968/pnur.2014.25.8.382
- By:
- Publication type:
- Article
The challenges of nursing the obese patient with a stoma.
- Published in:
- 2013
- Publication type:
- Case Study
Atypical pANCA as a marker of indeterminate colitis for the prediction of ulcerative colitis and crohn's disease.
- Published in:
- Wiener Klinische Wochenschrift, 2013, v. 125, n. 9/10, p. 279, doi. 10.1007/s00508-013-0363-x
- By:
- Publication type:
- Article
Autoantibodies pANCA, GAB and PAB in inflammatory bowel disease: prevalence, characteristics and diagnostic value.
- Published in:
- Wiener Klinische Wochenschrift, 2010, v. 122, p. 19, doi. 10.1007/s00508-010-1344-y
- By:
- Publication type:
- Article
Centrifugal Leukocytapheresis Therapy for Ulcerative Colitis Without Concurrent Corticosteroid Administration.
- Published in:
- Therapeutic Apheresis & Dialysis, 2006, v. 10, n. 3, p. 242, doi. 10.1111/j.1744-9987.2006.00379.x
- By:
- Publication type:
- Article
Leukocytapheresis for Ulcerative Colitis: A Comparative Study of Anticoagulant (Nafamostat Mesilate vs. Dalteparin Sodium) for Reducing Clinical Complications.
- Published in:
- Therapeutic Apheresis & Dialysis, 2006, v. 10, n. 1, p. 54, doi. 10.1111/j.1744-9987.2006.00309.x
- By:
- Publication type:
- Article
Suppression of Inflammatory Cytokine Secretion by Granulocyte/Monocyte Adsorptive Apheresis in Active Ulcerative Colitis.
- Published in:
- Therapeutic Apheresis & Dialysis, 2005, v. 9, n. 2, p. 123, doi. 10.1111/j.1774-9987.2005.00229.x
- By:
- Publication type:
- Article
Successful Treatment of Ulcerative Colitis with Leukocytapheresis Using Non-woven Polyester Filter.
- Published in:
- Therapeutic Apheresis & Dialysis, 2003, v. 7, n. 6, p. 536, doi. 10.1046/j.1526-0968.2003.00096.x
- By:
- Publication type:
- Article
Studies on the Mechanisms of Leukocyte Adhesion to Cellulose Acetate Beads: An In Vitro Model to Assess the Efficacy of Cellulose Acetate Carrier-based Granulocyte and Monocyte Adsorptive Apheresis.
- Published in:
- Therapeutic Apheresis & Dialysis, 2003, v. 7, n. 3, p. 334, doi. 10.1046/j.1526-0968.2003.00049.x
- By:
- Publication type:
- Article
Extracorporeal Monocyte Granulocytapheresis was Effective for a Patient of Erythema Nodosum Concomitant withUlcerative Colitis.
- Published in:
- Therapeutic Apheresis & Dialysis, 2003, v. 7, n. 1, p. 122, doi. 10.1046/j.1526-0968.2003.00002.x
- By:
- Publication type:
- Article
Mirikizumab in moderately to severely active ulcerative colitis: a profile of its use.
- Published in:
- Drugs & Therapy Perspectives, 2024, v. 40, n. 11, p. 433, doi. 10.1007/s40267-024-01114-4
- By:
- Publication type:
- Article
Age is just a number with ulcerative colitis therapies.
- Published in:
- Drugs & Therapy Perspectives, 2023, v. 39, n. 7, p. 243, doi. 10.1007/s40267-023-01007-y
- By:
- Publication type:
- Article
A Role of a Lymphocyte Tryptase, Granzyme A, in Experimental Ulcerative Colitis.
- Published in:
- Bioscience, Biotechnology & Biochemistry, 2007, v. 71, n. 1, p. 234, doi. 10.1271/bbb.60354
- By:
- Publication type:
- Article
Auraptene Decreases the Activity of Matrix Metalloproteinases in Dextran Sulfate Sodium-Induced Ulcerative Colitis in ICR Mice.
- Published in:
- Bioscience, Biotechnology & Biochemistry, 2006, v. 70, n. 12, p. 3062, doi. 10.1271/bbb.60393
- By:
- Publication type:
- Article
Ecabet sodium attenuates reactive oxygen species produced by neutrophils after priming with bacterial lipopolysaccharides.
- Published in:
- Luminescence: Journal of Biological & Chemical Luminescence, 2003, v. 18, n. 6, p. 330, doi. 10.1002/bio.745
- By:
- Publication type:
- Article